Pharmacologic Characterization of Valbenazine (NBI-98854) and Its Metabolites.
The Journal of pharmacology and experimental therapeutics • Vol. 361, Issue 3 • 2017
Valbenazine: First Global Approval.
Drugs • Vol. 77, Issue 10 • 2017
NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.
Movement disorders : official journal of the Movement Disorder Society • Vol. 30, Issue 12 • 2015
Histamine (H2) receptor-adenylate cyclase system in pig skin (epidermis).
Biochimica et biophysica acta • Vol. 437, Issue 1 • 1976